Apolipoprotein A-I Mimetic Peptides for the Treatment of Coronary Artery Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6557|1|1|81-84

ISSN： 1573-403X

Source： Current Cardiology Reviews, Vol.1, Iss.1, 2005-01, pp. : 81-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidation hypothesis of atherogenesis: HDL inflammatory index and apolipoprotein A-I mimetic peptides

By Yu Roger   Navab Mohamad  

Future Cardiology, Vol. 3, Iss. 3, 2007-05 ,pp. : 309-319

Future Medicine

Access to resources Recommend Favorite

A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease

By Ikewaki K.   Matsunaga A.   Han H.   Watanabe H.   Endo A.   Tohyama J.-i.   Kuno M.   Mogi J.-i.   Sugimoto K.-i.   Tada N.   Sasaki J.   Mochizuki S.  

Atherosclerosis, Vol. 172, Iss. 1, 2004-01 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite

Proteomic Identification of Lower Apolipoprotein A-I in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 3, 2006-02 ,pp. : 155-161

Karger

Access to resources Recommend Favorite

Evidence of reduced coronary artery disease risk for apolipoprotein 2/3 heterozygotes

By Mamotte C.D.S.   Burke V.   Taylor R.R.   van Bockxmeer F.M.  

European Journal of Internal Medicine, Vol. 13, Iss. 4, 2002-06 ,pp. : 250-255

Elsevier

Access to resources Recommend Favorite

An Apolipoprotein A-I Gene Promoter Polymorphism Associated with Cognitive Decline, but Not with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 2, 2007-12 ,pp. : 97-102

Karger

Access to resources Recommend Favorite